Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Synlogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synlogic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Synlogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synlogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Synlogic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synlogic Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Synlogic Raises USD42 Million in Series C Financing 11
Synlogic Raises USD40 Million in Series B Venture Financing 13
Synlogic Raises USD17 Million Financing 15
Synlogic Raises Funds through Venture Financing 16
Synlogic Raises Additional USD5 Million in Series A Venture Financing 17
Synlogic Raises USD29.4 Million in Series A Venture Financing 18
Partnerships 19
Synlogic Enters into Partnership Agreement with Ginkgo BioWorks 19
Synlogic Enters into R&D Agreement with AbbVie 20
Synlogic Enters into R&D Agreement with Pharmaceutical Company 21
Merger 22
Synlogic and Mirna Therapeutics Merges in Reverse Merger Transaction 22
Equity Offering 24
Synlogic Plans to Raise up to USD200 Million in Public Offering of Securities 24
Synlogic Raises USD30 Million in Public Offering of Shares 25
Synlogic Completes Underwriters Exercise of Over-Allotment Option of Public Offering for USD57.5 Million 27
Synlogic Inc – Key Competitors 29
Synlogic Inc – Key Employees 30
Synlogic Inc – Locations And Subsidiaries 31
Head Office 31
Recent Developments 32
Financial Announcements 32
Aug 08, 2018: Synlogic reports second quarter 2018 financial results and provides program updates 32
May 15, 2018: Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update 34
Mar 20, 2018: Synlogic Reports Fourth Quarter and Full Year 2017 Financial Results 35
Nov 13, 2017: Synlogic Reports Third Quarter 2017 Financial Results and Recent Progress 37
Corporate Communications 39
Oct 02, 2018: Synlogic names Dr. Aoife Brennan as President and Chief Executive Officer 39
Oct 02, 2018: Synlogic names Dr. Aoife Brennan as President and Chief Executive Officer 40
May 10, 2018: Synlogic Announces Leadership Change 41
Oct 10, 2017: Synlogic Strengthens Leadership Team with Appointment of Chief Operating Officer and Chief Human Resources Officer 42
Product News 43
04/18/2018: Synlogic Doses First Subject in Phase 1/2a Trial of SYNB1618 for Treatment of Phenylketonuria 43
Product Approvals 44
Oct 24, 2017: Synlogic Receives Orphan Drug Designation for SYNB1618, a Synthetic Biotic Medicine for the Treatment of Phenylketonuria 44
Jun 26, 2017: Synlogic Receives Fast Track Designation in U.S. for Lead Candidate, SYNB1020 45
Clinical Trials 46
Mar 12, 2018: Synlogic Presents Preclinical Data on Synthetic Biotic Medicine SYNB1618 at Annual Meeting of The Society for Inherited Metabolic Disorders 46
Jan 05, 2018: Synlogic Provides Update on its Phenylketonuria Drug candidate SYNB1618 47
Jun 19, 2017: Synlogic Doses First Subject in Phase 1 Trial of Novel Class of Synthetic Biotic Medicines 48
Mar 22, 2017: Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
Synlogic Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Synlogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synlogic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Synlogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synlogic Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Synlogic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synlogic Raises USD42 Million in Series C Financing 11
Synlogic Raises USD40 Million in Series B Venture Financing 13
Synlogic Raises USD17 Million Financing 15
Synlogic Raises Funds through Venture Financing 16
Synlogic Raises Additional USD5 Million in Series A Venture Financing 17
Synlogic Raises USD29.4 Million in Series A Venture Financing 18
Synlogic Enters into Partnership Agreement with Ginkgo BioWorks 19
Synlogic Enters into R&D Agreement with AbbVie 20
Synlogic Enters into R&D Agreement with Pharmaceutical Company 21
Synlogic and Mirna Therapeutics Merges in Reverse Merger Transaction 22
Synlogic Plans to Raise up to USD200 Million in Public Offering of Securities 24
Synlogic Raises USD30 Million in Public Offering of Shares 25
Synlogic Completes Underwriters Exercise of Over-Allotment Option of Public Offering for USD57.5 Million 27
Synlogic Inc, Key Competitors 29
Synlogic Inc, Key Employees 30
List of Figures
Synlogic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synlogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synlogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synlogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synlogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synlogic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Synlogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synlogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9